Climate Health Medical

‘Communities take primacy in any conversation around health’: Interview

In our search for websites and organizations engaged in community health, public policy and similar endeavors, we came across “The Third Eye’.  Named.

Read More
Drugs Health Medical

Harvard develops drug-free nasal spray to block viruses, bacteria

Harvard University researchers have developed a drug-free nasal spray that blocks, and neutralizes viruses and bacteria.

Read More
Drugs Health Pharma

AstraZeneca’s experimental blood cancer drug gets US priority review

British-Swedish AstraZeneca’s drug for treatment of a form of blood cancer has been granted a Priority Review in the US by the drug.

Read More
Drugs Health Pharma

Gilead signs six global pacts to make, sell generic HIV preventive drug

Gilead Sciences, Inc. has signed non-exclusive, royalty-free voluntary licensing agreements with six pharmaceutical makers to make and sell its generic lenacapavir drug for the prevention.

Read More
Drugs Health Pharma

WHO reports new case of MERS-CoV in Saudi Arabia, risk ‘moderate’

The WHO has been notified of a human case of Middle East Respiratory coronavirus (MERS-CoV) in the Kingdom of Saudi Arabia.

Read More
Drugs Health Medical

Lilly to invest $4.5 billion to build Medicine Foundry in Indiana state, US

Eli Lilly and Company will build a $4.5 billion center for advanced manufacturing and drug development in Indiana to innovate new production methods.

Read More
Drugs Health Pharma

Amplifica’s human trial medicine for hair growth shows 15% more efficacy

Amplifica Holdings Group Inc.’s first-in-human trial of an injectable medicine for treating hair loss has shown a more than 15% increase in non-vellus.

Read More
Drugs Health Pharma

Brazil becomes 20th WHO-validated nation to eliminate lymphatic filariasis

Brazil became the 20th country in the world that has been validated by WHO to have eliminated lymphatic filariasis as a public health.

Read More
Drugs Health Pharma

J&J to build $2b facility in North Carolina to make future products

 HQ Team October 2, 2024: Johnson & Johnson will invest $2 billion to build a biologics manufacturing facility in Wilson, North Carolina, anticipating.

Read More
Climate Health Pharma

ADNOC to buy Germany’s chemical producer Covestro for $13 billion

The Abu Dhabi National Oil Company, ADNOC, the state-owned oil company of the United Arab Emirates, will buy Germany’s chemicals maker Covestro AG.

Read More
X